Triplet therapy with palbociclib, taselisib and fulvestrant in PIK3CA mutant breast cancer and doublet palbociclib and taselisib in pathway mutant solid cancers
scientific article published on 21 September 2020
Author/s
author: J Pascual, Joline S J Lim, Iain R Macpherson, Anne Armstrong, Alicia Okines, Maria Teresa Herrera-Abreu, Isaac Garcia-Murillas, Alex Pearson, Michael Hubank, Karen E Swales, Ruth Ruddle, Emma Hall, Timothy A Yap
Work details
Copyright status
Copyright status information is not available for this work. The copyright status depends on the jurisdiction, the author's date of death and the date the work was created or published.
To learn more about copyright terms in different countries, visit the countries and terms page.